§ 35-48-2-8 — Schedule III

(a) The controlled substances listed in this
section are included in schedule III.
(b) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
stimulant effect on the central nervous system, including its salts,
isomers (whether optical, position, or geometric), and salts of such
isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation:
(1) Those compounds, mixtures, or preparations in dosage unit
form containing any stimulant substances listed in schedule II
which compounds, mixtures, or preparations were listed on April
1, 1986, as excepted compounds under 21 CFR 1308.32, and any
other drug of the quantitative composition shown in that list for
those drugs or that is the same except that it contains a lesser
quantity of controlled substances (1405).
(2) Benzphetamine (1228).
(3) Chlorphentermine (1645).
(4) Clortermine (1647).
(5) Phendimetrazine (1615).
(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system:
(1) Any compound, mixture, or preparation containing:
(A) amobarbital (2126);
(B) secobarbital (2316);
(C) pentobarbital (2271); or
(D) any of their salts;
and one (1) or more other active medicinal ingredients which are
not listed in any schedule.
(2) Any suppository dosage form containing:
(A) amobarbital (2126);
(B) secobarbital (2316);
(C) pentobarbital (2271); or
(D) any of their salts;
and approved by the Food and Drug Administration for marketing
only as a suppository.
(3) Any substance which contains any quantity of a derivative of
barbituric acid, or any salt thereof (2100).
(4) Chlorhexadol (2510).
(5) Embutramide (2020).
(6) Lysergic acid (7300).
(7) Lysergic acid amide (7310).
(8) Methyprylon (2575).
(9) Sulfondiethylmethane (2600).
(10) Sulfonethylmethane (2605).
(11) Sulfonmethane (2610).
(12) A combination product containing Tiletamine and
Zolazepam or any salt thereof (Telazol) (7295).
(13) Any drug product containing gamma-hydroxybutyric acid,
including its salts, isomers, and salts of isomers, for which an
application is approved under section 505 of the federal Food,
Drug and Cosmetic Act, 21 U.S.C. 301 et seq. (2012).
(d) Nalorphine (a narcotic drug) (9400).
(e) Narcotic Drugs. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs, or their salts calculated
as the free anhydrous base or alkaloid, in the following limited
quantities:
(1) Not more than 1.8 grams of codeine, per 100 milliliters or not
more than 90 milligrams per dosage unit, with an equal or greater
quantity of an isoquinoline alkaloid of opium (9803).
(2) Not more than 1.8 grams of codeine, per 100 milliliters or not
more than 90 milligrams per dosage unit, with one (1) or more
active, nonnarcotic ingredients in recognized therapeutic amounts
(9804).
(3) Not more than 1.8 grams of dihydrocodeine, per 100 milliliters
or not more than 90 milligrams per dosage unit, with one (1) or
more active, nonnarcotic ingredients in recognized therapeutic
amounts (9807).
(4) Not more than 300 milligrams of ethylmorphine, per 100
milliliters or not more than 15 milligrams per dosage unit, with
one (1) or more active, nonnarcotic ingredients in recognized
therapeutic amounts (9808).
(5) Not more than 500 milligrams of opium per 100 milliliters or
per 100 grams or not more than 25 milligrams per dosage unit,
with one (1) or more active, nonnarcotic ingredients in recognized
therapeutic amounts (9809).
(6) Not more than 50 milligrams of morphine, per 100 milliliters
or per 100 grams with one (1) or more active nonnarcotic
ingredients in recognized therapeutic amounts (9810).
(7) Buprenorphine (9064).
(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21
U.S.C. 802(41)(B)).
(g) The board shall except by rule any compound, mixture, or
preparation containing any stimulant or depressant substance listed in
subsections (b) through (e) from the application of any part of this
article if the compound, mixture, or preparation contains one (1) or
more active medicinal ingredients not having a stimulant or depressant
effect on the central nervous system, and if the admixtures are included
therein in combinations, quantity, proportion, or concentration that
vitiate the potential for abuse of the substances which have a stimulant
or depressant effect on the central nervous system.
(h) Any material, compound, mixture, or preparation which contains
any quantity of Ketamine (7285).
(i) Hallucinogenic substances:
Dronabinol (synthetic) in sesame oil and encapsulated in a soft
gelatin capsule in a United States Food and Drug Administration
approved drug product (7369).
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts
1977, P.L.2, SEC.86; Acts 1979, P.L.303, SEC.5; Acts 1981, P.L.170,
SEC.4; P.L.333-1983, SEC.3; P.L.200-1987, SEC.10; P.L.48-1991,
SEC.76; P.L.1-1994, SEC.171; P.L.31-1998, SEC.10; P.L.288-2001,
SEC.16; P.L.22-2008, SEC.3; P.L.56-2015, SEC.4.